Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Change in Receivables (2020 - 2025)

Historic Change in Receivables for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $1.2 million.

  • IM Cannabis' Change in Receivables rose 17024.64% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 26866.02%. This contributed to the annual value of -$4.6 million for FY2024, which is 36705.47% down from last year.
  • As of Q3 2025, IM Cannabis' Change in Receivables stood at $1.2 million, which was up 17024.64% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' Change in Receivables registered a high of $4.4 million during Q3 2022, and its lowest value of -$5.2 million during Q2 2024.
  • In the last 5 years, IM Cannabis' Change in Receivables had a median value of $799682.9 in 2021 and averaged -$71202.0.
  • The largest annual percentage gain for IM Cannabis' Change in Receivables in the last 5 years was 48900.64% (2021), contrasted with its biggest fall of 332331.36% (2021).
  • Over the past 5 years, IM Cannabis' Change in Receivables (Quarter) stood at $799682.9 in 2021, then soared by 346.16% to $3.6 million in 2022, then rose by 3.74% to $3.7 million in 2023, then plummeted by 63.31% to $1.4 million in 2024, then fell by 10.39% to $1.2 million in 2025.
  • Its Change in Receivables was $1.2 million in Q3 2025, compared to $3.5 million in Q2 2025 and -$2.3 million in Q1 2025.